4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-129258
General Counsel sold 432 shares at $0.55 ($237)
From the SEC's structured data for this filing
Trades in this filing
Miller Edward · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-19 | Sale : show line 1 in the form | −432 | $0.55 | $237 | 211,499 | D |
| Open-market sales · 432 sh · avg $0.55 · $237 | ||||||
Loading xslF345X05/ownership.xml…